PE just paid $650M for patient texting

The deal was announced on August 18 at $7.40 a share, a 34% premium, taking the patient engagement and payments platform private. Weave serves more than 40,000 healthcare practice locations and closes in Q4.

What got bought is not a marketing tool. It is the layer that handles appointment reminders, payment requests, and the voice and text traffic between a practice and its patients.

Private equity does not pay a 34% premium for a nice-to-have. It paid for the messages patients actually read, and that should tell you something about where the value sits in a patient relationship.

Telehealth encounters rose 79% between January 2019 and January 2026, with remote patient monitoring up nearly 4,000% over the same period, according to Strata Decision Technology's Performance Trends report.

Average total cost margins for those telehealth encounters stayed negative across every major payer category.

Volume went up and the economics went the wrong way. The systems doing insured virtual care are running the same modality you are and losing money on it, which is worth remembering the next time someone describes telehealth as inherently high-margin.

The $835M acquisition, at $5.25 a share, completed in late August, folding one of the larger virtual behavioural health businesses into a hospital operator with more than 340 inpatient facilities.

Between this and Weave, the pattern in the last two weeks is incumbents and financial buyers acquiring virtual care delivery and the communication layer around it.

Nobody is paying these multiples for an acquisition funnel. They are paying for installed patient relationships and the infrastructure that maintains them.

The best-performing messages your patients receive are almost certainly not the ones your lifecycle program sends.

A private equity firm just paid $650 million for a company whose product is appointment reminders and payment requests.

Meanwhile most telehealth lifecycle programs are built entirely around campaigns and nurture flows, and treat the operational messages as somebody else's plumbing.

Think about what actually gets read in this category. "Your labs are ready." "Your order shipped." "Your payment failed." "Your provider left a note."

Those messages get opened at rates a promotional send will never touch, because the patient is waiting for them.

They also arrive at the exact moments that decide retention: the wait for lab results, the gap before approval, the failed card that quietly ends a subscription nobody cancelled.

Here is where it breaks. In most telehealth stacks those messages are scattered.

Each was set up once, by whoever stood up that system, and never revisited. They are usually unbranded, often badly written, and almost never instrumented, so they show up in no report you look at.

Every brand we audit has at least a handful of these running that the marketing team could not list from memory.

The failed-payment email is the clearest case. In a subscription business, involuntary churn from expired and declined cards is a meaningful share of total churn, and the only thing standing between that patient and a cancelled plan is a dunning message written by a payments vendor.

Rewriting it, branding it, and adding a second and third attempt costs an afternoon and recovers revenue you already earned.

The same logic runs through the rest of them. A lab-results notification that also sets expectations for the next step does more retention work than the nurture email you spent a week on.

Takeaway: stop drawing the line around "marketing emails" when you plan lifecycle work. The patient does not experience two channels, they experience one relationship, and the messages doing the most work in that relationship are the ones currently owned by nobody.

Plenty of cash-pay telehealth founders see insurance coverage as the obvious next growth lever. The Strata data is a useful counterweight: encounters up 79%, margins negative across every payer category.

Reimbursed virtual care carries billing overhead, denial management, and a rate you do not set.

That does not mean never, but it does mean the case for it has to be volume and defensibility, not margin. If the pitch to your board is that insurance improves unit economics, the systems already doing it are evidence against you.

Ecommerce Q4 advice does not port cleanly to telehealth. Your biggest intake month is January, when people act on a resolution, not December.

Which changes the Q4 job. It is not squeezing maximum revenue out of the fall cohort, it is keeping that cohort alive and on treatment through the holidays so they are still patients when the January wave arrives and your team is stretched.

Build the December retention plan now, in September, while there is time to test it. Holiday disruption, travel, missed doses and delayed refills are all predictable, and none of them get solved in week one of December.

Sign up as a patient in your own funnel and go all the way through to a first order.

Use a fresh email address and keep every message that arrives, from every system, not just the ones your ESP sent.

List them out with three columns: what triggered it, which system sent it, and whether you can see its open and click rate anywhere.

The rows with a blank third column are the ones running unmeasured, and in most telehealth stacks that is six to ten messages nobody on the team could have named.

Start with the failed-payment one. That is the row where a bad default template is costing you patients you already paid to acquire.

If retention is your biggest revenue leak, that’s what we fix. growthtrigger.xyz

Reply to this with your biggest retention challenge. I read and respond to every single one.